Electrochemical Behavior of Valsartan, Glimepiride and Their Interaction with Each Other Using Square Wave Voltammetry

Year 2019, Volume: 7 , 236 - 248, 24.11.2019

Amer Th. Al-taee Aws Z. Al-hafıdh

Abstract

In this work an electrochemical quantification and interaction of valsartan and glimepiride were studied on hanging mercury drop electrode (HMDE) using square wave voltammetric (SWV) technique. The effect of temperature on the interaction was investigated in eight degrees of heat and the thermodynamics parameters (enthalpy, entropy & free gibbs energy) were calculated for the interaction using Van't Hoff equation and binding constant (K) also obtained from interaction equation. From the values of the calculated thermodynamic parameters it found that the main bonding forces that predominated over the interaction were Vander Waals and Hydrogen bonding. The calibration curves of each drug was liner with R2 value equal to 0.9819, 0.997 and the limit of detection was found to be 4.99 x 10-7, 3.48 x 10-8 for valsartan and glimepiride respectively. Through the limit of detection, this method can be used as a standard method in estimating the pharmacists in pharmaceutics and verifying the credibility of the manufacturers of the two drugs.

Keywords

Square wave voltammetry (SWV), Valsartan, Glimepiride, Drug interaction

References

• Alfonso, M.S.F., Gayo, M.R. (2005). Fundamentos de Farmacología Básica y Clínica . Published by Steve Bob Billy Joe. Spain. page 232. Altinoz, S., Tekeli, D. (2001 Jan). Analysis of glimepiride by using derivative UV spectrophotometric method. J. Pharm. Biomed. Anal., 24(3), 507-515. Becic, F., Kapic, E., Becic, E. (2003). Glimepiride - an oral antidiabetic agent. Med. Arh., 57(2), 125-127. Campbell, R.K. (1998 Oct). Glimepiride: role of a new sulfonylurea in the treatment type 2 diabetes mellitus. Ann. Pharmacother., 32(10), 1044-1052. Davis, S.N. (2004 July). The role of glimepiride in the effective management of type 2 diabetes. J. Diabetes Complications., 18, 367-376. Draeger, E. (1995 Aug). Clinical profile of glimepiride. Diabetes Res. Clin. Pract., 28, S139-146. Habib, I.H.I., Weshahy, S.A., Toubar, S.S., El-Alamin, M.M.A. (2007 Dec). Stripping voltammetric determination of valsartan in bulk and pharmaceutical products, Pharmazie., 63, 337–341. Iriarte, G., Ferreiros, N., Ibarrondo, I., Alonso, R.M., Maguregui, M.I., Jimenez, R.M. (2007 June). Biovalidation of an SPE-HPLC-UV-fluorescence method for the determination of valsartan and its metabolite valeryl-4-hydroxy-valsartan in human plasma. J. Sep. Sci., 30, 2231. Jalali, F., Dorraji, P.S. (2012). Electrochemical and spectroscopic studies of the interaction between the neuroleptic drug, gabapentin, and DNA. J. Pharm. and Biomed. Anal., 70, 598– 601. Khan, I.U., Aslam, F., Ashfaq, M., Asghar, M.N. (2009 Feb). Determination of glimepiride in pharmaceutical formulations using HPLC and firstderivative spectrophotometric methods. J. Anal. Chem., 64(2), 171-175. Koseki, N., Kawashita, H., Hara, H., Niina, M., Tanaka, M., Kawai, R., Nagae, Y., Masuda, N. (2007 Jan). Development and validation of a method for quantitative determination of valsartan in human plasma by liquid chromatography-tandem mass spectrometry. J. Pharm. Biomed. Anal., 43, 1769. Langtry, H.D., Balfour, J.A. (1998 Apr). Glimepiride: a review of its use in the management of type 2 diabetes mellitus. Drugs., 55(4), 563-584. Macek, J., Klima, J., Ptacek, P. (2006 Jan). Rapid determination of valsartan in human plasma by protein precipitation and high-performance liquid chromatography. J. Chromatogr. B., 832, 169. Massimo, M. (2002 Dec). Glimepiride in type 2 diabetes mellitus: a review of the worldwide therapeutic experience. Clin. Ther., 25(3), 799-816. Mohapatra, S.S., Kafle, A., Reddy, I., Sarma, J. (2018). Drug interactions with antibiotics. International J. Chem. Studies, 6(2), 2120-2122 Nie, J., Zhang, M., Fan, Y., Wen, Y., Xiang, B., Feng, Y.Q. (2005, Oct). Biocompatible in-tube solid-phase microextraction coupled to HPLC for the determination of angiotensin II receptor antagonists in human plasma and urine. J. Chromatogr. B., 828, 62. Patel, J.R., Suhagia, B.N., Patel, M.M. (2006). Simultaneous determination of glimepiride and pioglitazone in bulk and in pharmaceutical formulations by HPTLC method. Asian J. Chem., 18(4), 2873-2878. Ramadan, N.K., Mohamed, H.M., Mostafa, A.A. (2012 Feb). Potentiometric determination of amlodipine besilate and valsartan using microsized and polymeric matrix membrane sensors. Portugaliae Electrochimica Acta., 30(1), 15-29. Ravindra, N., Singhvi, I. (2008 July). Spectrophotometric estimation of glimepiride from pharmaceutical dosage forms. Asian J. Chem., 20(6), 4379-4382. Ross, D. P., Subramanian, S. (1981). Thermodynamics of protein association reactions: forces contributing to stability. Biochemistry, 20, 3096-3102. Tatar, S., Saglik, S. (2002 May). Comparison of UV- and second derivative-spectrophotometric and LC methods for the determination of valsartan in pharmaceutical formulation. J. Pharm. Biomed. Anal., 30, 371. Wang, J., Yang, D.J., Wang, Z.T., Chen, B., Yao, S.Z. (2009 Mar). Simultaneous of illegal additives in dietary supplements and traditional medicines by high performance liquid chromatography-electrospray ionization mass spectrometry. Food Chem., 113(1), 227-232. Yan, J., Wang, W., Chen, L., Chen, S. (2008 Aug). Electrochemical behavior of valsartan and its determination in capsules. Colloids and Surfaces B., 67, 205–209.